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Abstract
Background: We earlier reported spontaneous features of asthma in Vasoactive Intestinal Peptide knockout mice
(VIP KO): 1) peribronchiolar airway inflammation, with accumulation of lymphocytes and eosinophils, 2) pro-
inflammatory cytokine production of IL-5, IL-6, with IFN-g, and 3) airway hyper-responsiveness to inhaled
methacholine. In human asthma, a phenotype with sulfite sensitivity leads to airway inflammation and hyper-
responsiveness to inhaled sulfites, and is associated with upregulation of anti-oxidant protein lung carbonyl
reductase. For the present experiments, we examined the role of VIP in modulating anti-oxidant genes and their
proteins, including lung carbonyl reductase.
Results: Four male VIP KO mice and four wild-type age- and gender matched mice had lungs examined for whole
genome microarray and a proteomics approach using mass spectrometry. The proteomics analysis revealed that a
novel variant of anti-oxidant protein lung carbonyl reductase (car3) was uniquely and markedly elevated in the VIP
KO mice. RT-PCR indicated that carbonic anhydrase 3, which is an anti-oxidant protein, was elevated in the VIP KO
mice.
Conclusions: These data support the concept that VIP influences the endogenous oxidant/antioxidant balance.
One potential implication is that VIP and its analogues may be used to treat inflammatory diseases, including
asthma.
Background
Asthma is an inflammatory airway disease with airway
hyper-responsiveness to inhaled irritants such as metha-
choline and aeroallergens. Vasoactive Intestinal Peptide
(VIP) is an endogenous anti-inflammatory peptide found
in airway nerve terminals and mast cells, which also has
potent airway smooth muscle relaxant properties [1].
We earlier reported that mice lacking VIP have the
spontaneous asthma phenotype: 1) peribronchiolar air-
way inflammation with lymphocytes and eosinophils,
and 2) airway hyper-responsiveness to inhaled metha-
choline. These Vasoactive Intestinal Peptide knockout
mice (VIP KO) prepared by disruption by homologous
recombination [2,3] have spontaneous airway inflamma-
tion, that is chronic, and airway hyper-responsiveness,
that does-dependently increases with methacholine in
the absence of allergic sensitization and challenge [1].
These features are consistent with the asthma pheno-
type. There is upregulation of pro-inflammatory and
pro-remodeling genes [4]. Th1 and Th2 pro-inflamma-
tory cytokines (IFN-g,I L - 5 ,I L - 6 )a r eu p r e g u l a t e di n
bronchoalveolar lavage fluid (BALF) spontaneously–
without the need for antigenic sensitization and chal-
lenge [1].
In human asthma, a phenotype with sulfite sensitivity,
leads to airway inflammation and hyper-responsiveness
to inhaled sulfites, and is associated with upregulation
of anti-oxidant protein lung carbonyl reductase [5].
Using a combination of genomics and proteomics meth-
odologies, we aimed to determine if genes and their pro-
teins implicated in the pathogenesis of asthma, such as
anti-oxidant proteins, are modulated by the VIP gene,
suggesting a mechanism of anti-asthma action by VIP.
These experiments tested the hypothesis that VIP KO
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Methods
Tissue Preparation
Four male Vasoactive Intestinal Peptide Knockout (VIP
KO) mice, ages 4-6 weeks, and four age- and gender
-matched wild-type (WT) C57BL/6 mice were anesthe-
tized with pentobarbital (100 mg/kg i.p.), and the lungs
were removed, placed in polypropylene tubes and quick
frozen by immersion in liquid nitrogen. The tissue was
stored at -80°C. Subsequently, the tissue was partially
thawed to permit dissection of a portion of the lung, the
remainder being quick frozen and returned to -80°C.
The dissected portion was transferred to a pre-cooled
porcelain mortar containing approximately 1 ml of
liquid nitrogen (N2). The tissue was pulverized with a
pre-cooled pestle, and the powdered tissue was trans-
ferred to a tared polypropylene tube and weighed. Solu-
bilization buffer –consisting of 7 M Urea, 2M Thiourea,
4% 3-[(3-Cholamidopropyl)dimethylammonio]-1-propa-
nesulfonate (CHAPS), 50 mM Dithiothreitol (DTT) and
1 mM phenylmethanesulphonylfluoride (PMSF)–was
added to the powdered tissue at a ratio of 10 μl per mg
tissue. The suspension was vortexed with a Vortex
Genie
® set at maximum speed for 4 × 15 second inter-
vals, with approximately 3 minutes of ice bath cooling
of the tube between intervals. The tubes containing the
tissue suspension were subsequently sonicated for 10
min. in a Fischer Scientific FS-28 bath sonicator filled
with ice-cold water. The tubes were subsequently incu-
bated at 4°C for 2-4 h and centrifuged in a Sorval SM24
rotor at 15,000 rpm, 30 min, 20°C, and the resulting
supernatant was transferred to a new polypropylene
tube. Aliquots were taken to determine protein concen-
tration, and the residual supernatant was quick frozen
in liquid N2 and stored at - 80°C. Protein concentration
was determined using a modification of the Peterson
method [6] that incorporated additional 6% Trichloroa-
cetic acid (TCA) washes to remove DTT, which inter-
feres with the assay. Protein yield was about 0.1 mg/mg
powdered tissue.
2-DE and Image Analysis
An aliquot of the solubilized protein was further washed
using the Bio-Rad ReadyPrep™ 2-D Cleanup Kit accord-
ing to kit instructions. The resulting pellet was solubi-
lized in 1D buffer containing 7 M urea, 2M thiourea, 4%
CHAPS, 50 mM DTT and 0.2% Bio-Rad Biolyte (3-10),
centrifuged 5 min, 13,000 rpm to remove any insoluble
residuals and the concentration of the solubilized pro-
tein was determined as described above. 200 μlo f1 D
buffer containing 100 μg protein and 0.0002% bromo-
phenol blue was passively equilibrated 17-19 h with a
Bio-Rad 11 cm ReadyStrip™ IPG strip, pH range 3-10.
The protein was subjected to isoelectric focusing using a
Bio-Rad Protean
® IEF Cell at a final focusing voltage of
8000 volts and a cumulative 35000 VH. Subsequently,
the IPG strips were reduced and equilibrated in SDS for
10 min in Equilibration Buffer I and alkylated for 10
min in Equilibration Buffer II as described in the Ready-
Strip™ IPG Strip Instruction Manual (p.19). For the
second dimension, the IPG strips were transferred to
Bio-Rad Criterion Tris-HCl gel, 8-16% resolving, 4%
stacking gel as described in the ReadyStrip™ IPG Strip
Instruction Manual. The gels were resolved at room
temperature under constant 200 V. Gels were run for
each individual mouse (four WT and four KO) as well
as pooled samples from WT and KO animals. Pooled
samples were formed by mixing equal quantities of pro-
tein from each animal in the respective group. The slab
gels were stained with 100 ml of SYPRO
® Ruby Stain
according to the Bio-Rad instruction manual and
imaged with a Bio-Rad VersaDoc™ 3000 Imaging Sys-
tem. The resulting images were analyzed using Bio-Rad
PDQuest Advanced 2-D Analysis Software, version 8.0.
Briefly, the images were analyzed and matched with the
following parameters: (1) warp gel images before match-
ing spots; (2) Gaussian model during testing; (3) vertical
and horizontal streaking removal; (4) background
removal; (5) smoothing with Power Mean filter, kernel
size 3 × 3; (6) spot normalization using local regression
model
In-gel Digestion and Protein Identification
Protein spots identified as being unique to WT and KO
groups were excised using a Bio-Rad ProteomeWorks™
Plus Spot Cutter with a 1.5 mm cutting tip and deliv-
ered to a 96-well plate. Comparable sized excisions of
blank regions of the gels were taken to serve as back-
ground references during sample processing. The
excised gel pieces were destained, reduced, aklyated and
digested with trypsin (Promega Gold, Mass Spectrome-
try Grade), essentially as described by Shevchenko et al.
(1996) [7] with minor modifications. The resulting con-
centrated peptide extract was diluted into a solution of
2% Acetonitrile (ACN), 0.1% Formic Acid (FA) (Buffer
A) for analysis.
The peptide mixture was analyzed by automated
microcaplillary liquid chromatography-tandem mass
spectrometry. Fused-silica capillaries (100 μmi . d . )w e r e
pulled using a P-2000 CO2 laser puller (Sutter Instru-
ments, Novato, CA) to a 5 μm i.d. tip and packed with
10 cm of 5 μm Magic C18 material (Agilent, Santa
Clara, CA) using a pressure bomb. This column was
then placed in-line with a Dionex Ultimate 3000
equipped with an autosampler. The column was equili-
brated in buffer A, and the peptide mixture was loaded
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pump flowed at 100 μL/min, and the flow rate to the
electrospray tip was reduced to ~ 200-300 nL/min by a
split. The HPLC separation was provided by a gradient
between Buffer A (2% ACN,0 . 1 %F A )a n dB u f f e rB
(98% ACN, 0.1% FA). The HPLC gradient was held con-
stant at 100% buffer A for 20 min after peptide loading
followed by a 30-min gradient from 0% buffer C (100%
Buffer A) to 40% buffer B. Then, the gradient was
switched from 40% to 80% buffer B over 3 min and held
constant for 3 min. Finally, the gradient was changed
from 80% buffer B to 100% Buffer A over 1 min, and
then held constant at 100% Buffer A for 40 more min-
utes. The application of a 1.8 kV distal voltage electro-
sprayed the eluted peptides directly into a Thermo
Fisher Scientific LTQ XL ion trap mass spectrometer
equipped with a nanoLC electrospray ionization source
(ThermoFinningan, San Jose, CA). Full mass spectra
(MS) were recorded on the peptides over a 400-2000 m/
z range, followed by five tandem mass (MS/MS) events
sequentially generated in a data-dependent manner on
the first, second, third, fourth and fifth most intense
ions selected from the full MS spectrum (at 35% colli-
sion energy). Mass spectrometer scan functions and
HPLC solvent gradients were controlled by the Xcalibur
data system (ThermoFinnigan, San Jose, CA).
MS/MS spectra were extracted from the RAW file
with Readw.exe (http://sourceforge.net/projects/sashimi).
The resulting mzXML file contains all the data for all
MS/MS spectra and can be read by the subsequent ana-
lysis software. The MS/MS data was searched with
Inspect
2 against a mouse IPI database (Ver. 3.43) with
optional modifications: +16 on Methionine, +57 on
Cysteine, +80 on Threonine, Serine and Tyrosine. Only
peptides with at least a p value of 0.01 were analyzed
further. Common contaminants (e.g. keratins) were
r e m o v e df r o mt h ed a t a .P r o t e i n si d e n t i f i e db ya tl e a s t3
distinct peptides within a sample were considered valid;
when sample signal was very weak, 2 distinct peptides
were accepted for a valid identification.
Whole Genome Agilent Microarray Analysis
Five VIP KO and 5 wild-type mice were anesthetized
and lungs were removed, flash frozen in liquid nitrogen
and sent to SAB Biosciences for analysis. Microarray
data were collected using the Whole Mouse genome (4
× 44 K) oligo microarray kit with Sureprint technology
(Agilent Technologies 395 Page Mill Rd, Palo Alto, CA
94306). These arrays contain probes for 41,000+ mouse
genes and transcripts represented, all with public
domain annotations. The enriched array content
sourced from UCSC, RefSeq, RIKEN, NIA, Ensembl,
UCSC Goldenpath, and Unigene databases. Over 70% of
the represented probes are validated by Agilent’s labora-
tory validation process.
RNA extraction
The lungs were homogenized in 2 ml of TRIzol, using a
Polytron homogenizer (VWR). RNA extraction was
done following the TRIzol protocol (Invitrogen, Carls-
bad, CA, Cat. # 15596-026).
RNA quality control
RNA samples were run on the Agilent Bioanalyzer. The
integrity of RNA was assessed by looking at 18 & 28s
rRNA peaks and by the RNA integrity number (RIN).
We also took the concentration of RNA on the nano
drop and made sure that the 260/280 ratio was above
2.0 and the 260/230 ratio was above 1.7.
Total RNA (0.6 μg) from 6 samples were reversed
transcribed into cDNA using T7dT24 primer containing
the poly T sequence and the promoter for T7 RNA
polymerase. After second strand synthesis, double-
stranded cDNA was used as the template to generate
complementary RNA (cRNA) in a modified “Eberwine”
type RNA amplification process. During this amplifica-
tion process, cRNA was labeled with aminoallyl-UTP
(Sigma). 8 μg Aminoallyl-cRNA each from 8 mouse
samples was conjugated with Cy3-NHS ester (GE
Healthcare) to generate Cy3-labelled cRNA.
Before each microarray hybridization, 1.65 micrograms
of Cy3-labelled cRNA was added to cRNA fragmenta-
tion mix. After the fragmentation reaction was stopped
by adding hybridization buffer, the mixture was loaded
onto a Whole Mouse Genome Oligo Microarray
assembly.
Hybridization was done at 65°C and 4 rpm for 17
hours. After that, the Whole Mouse Genome Oligo
Microarray assembly was dissembled in hybridization
wash buffer 1 (2× SSC, 1% SDS) at room temperature.
The microarray slides were washed in fresh hybridiza-
tion wash buffer 1 for 1 minute, followed by 1 minute
in 37°C hybridization wash buffer 2 (0.1× SSC, 0.5%
SDS), 1 minute in room temperature acetonitrile and 30
seconds in the stabilization and drying solution.
The dried microarray slide was scanned into a TIFF
image file on an Agilent microarray scanner at 5 μm
resolution using default settings. Microarray intensity
data were extracted from the TIFF image using Agilent
Feature Extraction Software 9.1.3.
Data Analysis
The raw data file containing raw intensities was
exported to Gene spring Software GX. We eliminated
data for all the control probes and data from genes
which were absent in all the samples. We further
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expression differences among 2 groups are more than 2
fold and a p value cut off of less than 0.05.
Results
Lung tissue was dissected from wild type C57BL/6 (WT)
and VIP knock-out (KO) mice and the resultant cell
lysate was subjected to two-dimensional gel electrophor-
esis as described in the METHODS section. Approxi-
mately 650 spots were detected per gel. Statistical
analysis using the Student’s t-test algorithm in the
PDQuest software indicated 64 spot variations between
KO and WT groups. Qualitative analysis indicated 3
spots (minimum 10 fold over background) in WT that
were not in KO and 3 spots in KO that were not in
WT. We focused our protein identification analysis on
these spots.
Figure 1 shows Sypro Ruby stained two dimensional
polyacrylamide gels of proteome extracts from wild type
(WT) and knockout (KO). Analysis of spot optical den-
sity using PDQuest software, as described in METH-
ODS, indicated a small number of protein spots with
density differences between the two samples. Sample
spot protein (SSP) numbered 3204, 3304 and 6304 are
circled in Figure 1A and were either absent or had a
much lower optical density in the KO sample. SSPs
numbered 7105, 7205 and 8101 are circled in Figure 1B
and were determined to be absent in the WT sample.
Figure 2 shows the master gel image, a composite gel
constructed by the PDQuest software, that contains all
significant spots from the eight gels used in this study.
The spots of interest are indicated and the inserts dis-
play histographs of spot optical density. Each histograph
bar represents the optical density of the respective spot
in each of the eight gels. Table S1 in the Additional file
1 gives the numeric values for the spot densities in each
o ft h eg e l s .T h es a m es p o t sw e r ee x c i s e df r o me a c hg e l ,
pooled, subjected to in-gel digestion with trypsin and
the resulting peptides analyzed by LC/MS/MS as
d e s c r i b e di nM E T H O D S .W h e nm o r et h a no n ep r o t e i n
was identified in a spot digest, the predominant protein
from each spot was determined based upon the spectral
count, the number of peptides identified and the cover-
age of the protein. To further eliminate ambiguity in
spot identification, the composition of comparable
regions in both KO and WT gels were compared. The
results of these determinations and a summary of spot
optical density quantification are given in Table 1.
As indicated in Figure 2 and quantified in Table 1, SSP
numbers 3204, 3306 and 6304 have higher optical den-
sity in WT samples with WT/KO optical density ratios
of 8.5, 4.3, and 7.6, respectively, suggesting that the
expression of the proteins responsible for these spots
may be down regulated or suppressed in the KO
samples. SSP 3304 was composed of, in the main, pyru-
vate dehydrogenase, guanidine nucleotide-binding pro-
tein and annexin-3. SSP 3204 was mainly composed of
superoxide dismutase, annexin 3 and chloride intracellu-
lar channel protein 5. To further resolve the complexity
of these spots we examined the protein composition in
the regions of the KO gels that correspond to these
spots. Analysis of the 3304 spot location in KO gels
revealed the presence of comparable amounts of guani-
dine nucleotide-binding protein and annexin-3, but no
pyruvate dehydrogenase. Likewise, analysis of the 3204
spot location in KO gels indicated that superoxide dis-
mutase was only present in this location in the WT gels.
We therefore conclude that the increased optical density
in SSP 3304 and 3204 are due the presences of pyruvate
dehydrogenase and superoxide dismutase, respectively.
SSP 6304 was identified as glycerol-3 phosphate dehy-
drogenase. We also see in Figure 2 that SSPs 7105, 7205
and 8101 have higher optical density in the KO samples
and are essentially absent in the WT gels (quantified in
Table 1) indicating that the proteins responsible for
these spots are up-regulated in the KO tissue. SSP 7105
was identified as triosphosphate isomerase, SSP 7205
was identified as dihydropteridine reductase and SSP
8101 was identified as carbonyl reductase.
As shown in Table 1, the theoretical molecular weight
(MW) and pI for most of the above proteins agree rea-
sonably well with the observed values. The one major
exception was SSP 8101. A 3-dimensional pixel density
profile of the region encompassing SSP 8101 in the WT
and KO gels of Figure 1 is shown in Figure 3, indicating
the location of SSP 8101. Carbonyl reductase has a theo-
retical MW and pI of 25,960 and 9.1 respectively. SSP
9206, its location indicated in Figures 1 and 2, was iden-
tified as carbonyl reductase by LC/MS/MS analysis and
found to be of equal abundance in both KO and WT
samples (Table 1). Spot 8101 therefore results from an
isomer of carbonyl reductase that is significantly abun-
dant in KO tissue but essentially absent in WT. As
noted in Table 1, Spots 8101 and 9206 migrate in the
gel with essentially identical Mr indicating a change in
pI without a substantial change in protein mass. There
are four isomers of carbonyl reductase (Cbr1-4). The
greatest sequence identity exists between Cbr1 and
Cbr3. Cbr2 has <30% sequence identity or similarity
with the other isomers. All carbonyl reductase peptides
identified in spot 8101 were unique to Cbr2.
The following proteins were upregulated in VIP KO
mice: lung carbonyl reductase, Triosephosphate isomer-
ase, Dihydropteridine reductase.
Lung carbonyl reductase (SSP 8101 and 9206)
(Cbr2) is an anti-oxidant protein responsible for lung
protection against inflammation and fibrosis
3.A n o t h e r
strain of mice (A/J) is resistant to lung inflammation
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mice strongly upregulate five anti-oxidant proteins
(superoxide dismutase 1 (Sod1), cytochrome c oxidase,
glutamate dehydrogenase, biliverdin reductase, peroxire-
doxin and carbonyl reductase) in lung, in response to
exposure to ionizing radiation
3. In contrast, wild-type
C57BL/6 mice up-regulate only one of these 5 anti-oxi-
dant proteins (lung carbonyl reductase 2) and have lung
inflammation and fibrosis at low doses of radiation
exposure.
3 The VIP KO mice are backcrossed to
C57BL/6. While there are minimal changes in genomic
expression of these 5 proteins, there is strong expression
of a lung carbonyl reductase isomer that has an altered
isolectric point shifted from pI 9.1 to pI 7.8. It is unclear
at this time whether the altered pI is due to a transla-
tional or post translation modification. Given that the
gene for lung carbonyl reductase was not significantly
changed in expression between VIP KO and WT mice
(Table 2), this would tend to support a mechanism of
posttranslational modification in VIP KO mice.
Figure 1 Two-dimensional gel electrophoresis of lung tissue samples obtained from wild type (WT) and VIP KO (KO) mice. The above
are typical images obtained from gels of both tissue types. The staining intensities of the protein spots were analyzed using BioRad PDQuest
software. The three spots (3204, 3304 and 6304) in the WT gel were significantly and substantially under-expressed in the KO gel. The three
spots (7105, 7205 and 8101) in the KO gel were significantly and substantially over-express in the KO gel. Spot 9206, encircled in both gels was
expresses at essentially equal levels in both gels.
Szema et al. BMC Immunology 2011, 12:66
http://www.biomedcentral.com/1471-2172/12/66
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regulated in all 4 VIP KO mice. There were no detect-
able SSP 7105 spots in the gels from all four WT mice
(p value = 0.017, Table 1). Tpi gene was 1.29 fold
increased in VIP KO vs. WT with a p value of 0.03.
(Table 2).
Dihydropteridine reductase (SSP 7205, Qdpr)was
strongly up-regulated in all four VIP KO mice. There
Figure 2 Master gel generated in PDQuest analysis. Inserts have histographs of the relative intensity of each spot in each of the eight gels
under study. The hatched bars in the histographs for SSP 9206 indicate optical saturation.
Table 1 Summary of SSP optical density and LC/MS/MS determined protein identity of the excised spots
SSP# Protein Symbol IPI
Accession
#
spectra peptides MW(kDa)/pI
calculated
MW(kDa)/pI
observed
a
Av
c
KO
OD
Av WT
OD
KO/
WT
WT/
KO
p value
(t-test)
7105 Triosephosphate
Isomerase
Tpi1 00467833 8 4 26.71/6.9 25.6/7.4 39301 0 ∞ 0 0.017
7205 Dihydropteridine
Reductase
Qdpr 00459279 5 3 25.57/7.7 27.1/7.5 222665 0 ∞ 0 0.032
8101 Carbonyl Reductase Cbr2 00128642 15 7 25.96/9.1 25.8/7.8 210771 2855 73.8 0.01 0.044
3304 Pyruvate
Dehydrogenase
Pdhb 00132042 36 13 38.94/6.4 37.1/5.6 72099 312442 0.23 4.33 0.011
3204 Superoxide Dismutase Sod3 00114319 12 4 27.39/6.4 32.8/5.6 10569 90285 0.12 8.54 0.002
6304 Glycerol-3-Phosphate
Dehydrogenase
Gpd1 00230185 16 8 37.57/6.8 36.6/6.9 19546 148182 0.13 7.58 0.038
9206 Carbonyl Reductase Cbr2 00128642 33 16 25.96/9.1 25.96/9.1
b 546335 521831 1.05 0.96 0.905
a Based on internal benchmarks.
b Served as one of four internal benchmarks.
c Average optical density of spots from four gels.
KO/WT and WT/KO are ratios of average optical densities and the t-Test p-values are two-tailed, unpaired determinations from four gels of each type.
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mice (p value = 0.0318, Table 1).
The following proteins were downregulated in VIP KO
mice: Pyruvate dehydrogenase, Extracellular superoxide
dismutase, Glycerol-3-phosphate
Pyruvate dehydrogenase (SSP 3304, Pdhb)E1 compo-
nent subunit beta, mitochondrial precursor catalyzes con-
version of pyruvate to acetyl coA and Co2 (Krebs cycle).
This enzyme was down-regulated in the VIP KO mice
with a WT/KO optical density ratio of 4.33 (Table 1).
Figure 3 Three-dimensional optical intensity profile of the region surrounding SSP 8101 in the KO gel and the corresponding region
in the WT gel. The profile was generated by the PDQuest software.
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Sod3)is an anti-oxidant protein that destroys radicals
which are normally produced within cells and which are
toxic to biological systems; it has NMDA receptor asso-
ciated protein activity. The optical density of SSP 3204
(Sod3) is substantially reduced in the gels from the KO
VIP mice (WT/KO = 8.54, Table 1). The genome micro-
array data indicated no significant change in Sod3. How-
ever, mRNA levels of both Sod1 and Sod2 were
somewhat reduced in the KO VIP mice with p values of
0.17 and 0.41, respectively (Table 2).
Glycerol-3-phosphate (SSP 6304, Gpd1, cytoplasmic)
is decreased in VIP KO mice with a WT/KO optical den-
sity ratio of 7.58 (Table 1). Gpd participates in the pentose
monophosphate shunt and leads to production of oxygen
free radicals. Perhaps down-regulation is a protective
mechanism. Our genome array studies (Table 2) indicated
no significant change in Gpd1 and that Gpd2 (mitochon-
drial) is up-regulated slightly (KO/WT = 1.3, p value =
0.009). There is no sequence overlap between Gpd1 and
Gpd2 and it is unclear whether the up-regulation of Gpd 2
is compensatory to the down-regulation of Gpd1.
I nt h eg e n o m ea r r a ys t u d i e s ,t h eg e n ef o rC a r b o n i c
anhydrase was highly upregulated in the KO mice. How-
ever, the protein was not identified in the proteomics
experiment, so we don’tk n o wi ft h ep r o t e i ni sn o t
modulated or if the protein is actually present.
Carbonic anhydrase (Car3)is increased significantly
(p value = 0.001, Table 2) with a 4.35 fold change on
gene microarray. Car3 catalyzes reversible hydration of
carbon dioxide leading to production of H2O2 and this
may account for increased peroxidation in VIP KO
mice.
Discussion
The following three protein were upregulated in VIP
KO mice and may modulate the asthma phenotype:.
Lung carbonyl reductase
Although we did not test the function of lung carbonyl
reductase in VIP KO mice, this different form may have
a bearing on function since the asthma phenotype is
present despite strong expression of the isomer. Lung
carbonyl reductase is essential in pulmonary metabolism
of endogenous compounds such as aliphatic aldehydes
and ketones derived from lipid peroxidation (anti-oxi-
dant), 3-ketosteroids and fatty aldehydes and is induced
by glucocorticoids and activated by fatty acids [8]. The
presence of an abnormal isomer may have a significant
impact on lung function.
This may be significant in asthma. Recent studies indi-
cate that there is an increase in reactive oxidant meta-
bolites in acute exacerbations of asthma [9]. These
authors studied 42 outpatients with acute exacerbations
of asthma, vs. 11 outpatients with a stable asthma vs.4 0
healthy humans. Serum reactive oxygen metabolite
levels were significantly higher in acute asthma exacer-
bations vs.s t a b l ea s t h m avs. healthy controls. Serum
eosinophil cationic protein and plasma polymorphonuc-
lear elastase were increased in acute exacerbations and
moderately correlated to reactive oxygen metabolite
levels. Reactive oxygen metabolite levels decreased with
systemic steroids and bronchodilators.
Since our mice have the spontaneous asthma pheno-
type, and asthma and its exacerbations are associated
with oxidation and reactive oxygen metabolites, then an
alteration in the isomeric make-up of anti-oxidant pro-
teins could explain why this asthma in VIP KO mice
does not spontaneously resolve. The normal endogenous
counter-regulatory mechanism against asthma may not
b ei n t a c to rm a yb ed i s r u p t e db yt h ep r e s e n c eo fa n
abnormal isomer. In fact, the asthma pathology worsens
with age in VIP KO mice, leading to increased inflam-
mation over time which is also consistent with an accu-
mulation of abnormal isomer with age.
Table 2 Summary of gene expression levels obtained from whole genome microarray analysis of WT and KO lung
tissue samples.
Gene Symbol Average KO Average WT KO/WT Fold change P value
triosephosphate isomerase 1 Tpi1 1.15 0.89 1.29 0.033
quininoid dihydropteridine reductase Qdpr 0.93 1.09 0.85 0.195
pyruvate dehydrogenase Pdhb 1.05 0.95 1.10 0.065
superoxide dismutase 1 Sod1 0.82 1.11 0.74 0.017
superoxide dismutase 2 Sod2 0.92 1.04 0.88 0.041
superoxide dismutase 3 Sod3 1.09 0.98 1.11 0.543
carbonyl reductase 2 Cbr2 1.00 1.02 0.97 0.630
carbonyl reductase 3 Cbr3 1.00 1.19 0.84 0.439
carbonic anhydrase 3 Car3 1.67 0.39 4.35 0.001
glycerol-3-phosphate dehydrogenase 1 Gpd1 1.83 0.66 2.76 0.095
glycerol-3-phosphate dehydrogenase 2 Gpd2 1.15 0.88 1.30 0.009
All of the above gene expression levels were confirmed by Real-Time PCR analysis (data not shown).
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implicated in the pathogenesis of asthma, VIP’sm e c h a n -
ism of action in reversing the asthma phenotype would
be its anti-oxidant effect. These data support the concept
of using VIP as an asthma drug. Other authors have reit-
erated the ample evidence of oxidative stress in asthma
but have highlighted the limited information regarding
endogenous anti-oxidant defense systems. Sackesen and
colleagues noted decreased glutathione peroxidases and
superoxide dismutase –significantly lower–in asthmatic
children vs. controls [10]. In our VIP KO mice, superox-
ide dismutase was strongly downregulated in protein
expression. Since childhood asthma is associated with
significant decreases in various components of both enzy-
matic and nonenzymatic anti-oxidant defenses, it follows
that VIP KO mice with the spontaneous asthma pheno-
type also lack or have reduced anti-oxidant proteins
(superoxide dismutase) or have abnormal forms of anti-
oxidant proteins (lung carbonyl reductase).
VIP therefore appears to contribute to modulation of
the oxidant/antioxidant balance in asthma, since wild-
type mice with VIP have functional lung carbonyl reduc-
tase and no spontaneous asthma, whereas VIP KO have
abnormal carbonyl reductase and have spontaneous
asthma. A glutathione gene variant GSTP1 has been
linked as a susceptibility gene for childhood asthma
[11]. It follows that pro-oxidant states are pro-asthmatic
and endogenous mechanisms that are anti-oxidant, such
as VIP, which scavenges singlet oxygen, are potently
anti-asthmatic.
Triose phosphate isomerase
Tpi is important in carbohydrate biosynthesis and gluco-
neogeneis and glycolysis. This may lend support to the
concept of diabetes in VIP KO mice. Of relevance to the
asthma model is that triose phosphate isomerase and
glyceraldehyde 3- phosphate 3 dehydrogenase were the
second and third most upregulated proteins in a proteo-
mics analysis of lungs from inflamed ovalbumin sensi-
tized and challenged C57BL/6 mouse model of asthma
[12]. If there is a limited supply of oxygen, cells are
dependent on the glycolytic pathway for anaerobic ATP
production; many of the glycolytic enzymes are upregu-
lated during hypoxia.
Dihydropterine reductase
Dihydropteridine reductase is a product of enzyme tet-
rahydrobiopterin (BH-4) which is an essential cofactor
for phenylalanine, tyrosine, tryptophan hydrolase. It is
important for eNOS production. Tetrahydrobiopterin is
a key factor in the production of nitric oxide in mast
cells [13]. Nitric oxide synthase (NOS) has obligate
requirements for BH4. Increased levels of dihydropteri-
dine reductase would be consistent with increased
endogenously produced NO by mast cells, which is con-
sistent with the spontaneous high IgE levels in VIP KO
mice and the asthma phenotype (Szema, unpublished
data).
The following three protein were downregulated in
VIP KO mice:
Pyruvate dehydrogenase
Decreased glycolysis would mean decreased available
ATP. Perhaps this may explain impaired thermogenesis
in VIP KO mice.
Decreased pyruvate dehydrogenase may be important
in asthma because alterations in affinity of acetyltransfer-
ase for acetyl coA and in the regulation of enzyme activ-
ity may occur in acute asthma. Neutrophils from patients
with acute asthma have increased levels of acetyltransfer-
ase activity which regulate production of platelet activat-
ing factor in inflammatory cells. Downregualtion of
pyruvate dehydrogenase in VIP KO ice would therefore
be a counter-regulatory mechanism [14].
Extracellular superoxide dismutase
Superoxide dismutase decrease would explain the lack of
protection from inflammation in VIP KO mice. It is
consistent with the inability of the VIP KO mice to
mount an anti-oxidant response. In agreement with
Sackesen et al., [10] superoxide dismutase is decreased
in asthmatic states in humans; we see this in our asth-
matic VIP KO mice.
Glycerol-3-phosphate
As a hypoxia-induced protein up-regulated under condi-
tions of allergic airway inflammation, glycerol-3-phos-
phate dehydrogenase is a marker protein for allergic
airway inflammation and its down-regulation in VIP KO
mice may be part of a compensation response [15].
The gene for carbonic anhydrase was upregulated in VIP
KO mice
Carbonic anhydrase
Acetazolamide, a carbonic anhydrase inhibitor, increased
the provocative concentration of a substance (methacho-
line) causing a 20% fall in the maximal amount of air for-
cefully exhaled in one second also known as the Forced
Expired Volume in 1 second or FEV1 (log PC20) and was
protective against sodium metabisulfite-induced challenge
in mild asthma. Since carbonic anhydrase activity in the
airways modulates bronchial hyperresponsiveness to meta-
bisulfite challenge, the increased expression of carbonic
anhydrase in VIP KO mice would be protective [15].
Conclusions
This study presented a combined genomic and proteo-
mic comparison of expression levels in WT and VIP KO
Szema et al. BMC Immunology 2011, 12:66
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Page 9 of 10mice. While revealing some striking changes, the data
also reveal a generally poor correlation between chnages
in transcriptomic and proteomic expression levels. This
observation is consistent with other more extensive inte-
grated studies of genomic and proteomic expression
data that demonstrated that such data sets can be
weakly correlated [16,17]. The reasons for this poor cor-
relation may lie both in the nature of the analysis as
well as the distinct regulatory mechanisms affecting
transcriptomic and proteomic expression levels. The
observation nonetheless underscores the importance of
the combined approach.
These data support the concept that VIP mediates the
pathogenesis of asthma by influencing the endogenous
oxidant/antioxidant balance. VIP is resident in neural
cells and mast cells and lymphocytes in humans. As an
endogenous peptide, VIP’s role in the oxidant/antioxi-
dant balance is highlighted by up-regulation of carbonic
anhydrase and a novel lung carbonyl reductase. Therapy
with VIP therefore has justification, especially in those
allergic asthmatics and in those whose disease is oxi-
dant-rich such as severe asthmatics in exacerbation.
Carbonic anhydrase was upregulated significantly
according to gene microarray analysis and correlated
with the clinical phenotype of airway hyperresponsive-
ness to methacholine in VIP KO mice; this is relevant as
asthma in humans with mild reactions to sodium meta-
bisulfite or sulfite sensitivity have increased levels of car-
bonic anhydrase. This lends support for VIP as a novel
medicine to treat a subset of asthmatics who have air-
way hyperresponsiveness in particular to sodium metabi-
sulfite which is ubiquitous in red wine, a product of the
yeast Saccaryomyces cerevisiae in beer, and is often used
in to preserve sundry foods.
Additional material
Additional File 1: Table S1 - Upper panel gives the pixel density of
the SSP spots in each of the eight gels (4 WT & 4KO). The lower
panel gives the average data used in Table 1.
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